Guerbet cuts jobs as contrast agent market stagnates
This article was originally published in Clinica
Executive Summary
Guerbet is to cut more than a tenth of its workforce in a restructuring programme aimed at improving the French company's position in the shrinking contrast agent market. The measures are expected to cost around Fr80 million ($13.5 million) and will be funded in 1998, which will result in a loss this year. The cuts are expected to result in annual savings of around Fr49 million.